9249 |
Ab00146-10.3 |
Anti-TNF alpha [cA2 (Infliximab)] |
200 μg |
支 |
4680.00 |
9250 |
Ab00146-10.0-BT |
Anti-TNF alpha [cA2 (Infliximab)] |
1 mg |
支 |
19920.00 |
9251 |
Ab00146-10.0 |
Anti-TNF alpha [cA2 (Infliximab)] |
200 μg |
支 |
4680.00 |
9252 |
Ab00144-23.0-BT |
Anti-Polyglutamine repeats [3B5H10] |
1 mg |
支 |
19920.00 |
9253 |
Ab00144-23.0 |
Anti-Polyglutamine repeats [3B5H10] |
200 μg |
支 |
4680.00 |
9254 |
Ab00144-1.1-BT |
Anti-Polyglutamine repeats [3B5H10] |
1 mg |
支 |
19920.00 |
9255 |
Ab00144-1.1 |
Anti-Polyglutamine repeats [3B5H10] |
200 μg |
支 |
4680.00 |
9256 |
Ab00143-23.0-BT |
Anti-P-glycoprotein [MRK16] |
1 mg |
支 |
19920.00 |
9257 |
Ab00143-23.0 |
Anti-P-glycoprotein [MRK16] |
200 μg |
支 |
4680.00 |
9258 |
Ab00143-1.1-BT |
Anti-P-glycoprotein [MRK16] |
500 μg |
支 |
26520.00 |
9259 |
Ab00143-1.1-BS |
Anti-P-glycoprotein [MRK16] |
1 mg |
支 |
47160.00 |
9260 |
Ab00143-1.1 |
Anti-P-glycoprotein [MRK16] |
100 μg |
支 |
6360.00 |
9261 |
Ab00142-23.0-BT |
Anti-p53 [PAb421] |
1 mg |
支 |
19920.00 |
9262 |
Ab00142-23.0 |
Anti-p53 [PAb421] |
200 μg |
支 |
4680.00 |
9263 |
Ab00142-2.0-BT |
Anti-p53 [PAb421] |
1 mg |
支 |
19920.00 |
9264 |
Ab00142-2.0 |
Anti-p53 [PAb421] |
200 μg |
支 |
4680.00 |